Cargando…

Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity

The autophagy-lysosomal pathway is impaired in many neurodegenerative diseases characterized by protein aggregation, but the link between aggregation and lysosomal dysfunction remains poorly understood. Here, we combine cryo-electron tomography, proteomics, and cell biology studies to investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Riera-Tur, Irene, Schäfer, Tillman, Hornburg, Daniel, Mishra, Archana, da Silva Padilha, Miguel, Fernández-Mosquera, Lorena, Feigenbutz, Dennis, Auer, Patrick, Mann, Matthias, Baumeister, Wolfgang, Klein, Rüdiger, Meissner, Felix, Raimundo, Nuno, Fernández-Busnadiego, Rubén, Dudanova, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711852/
https://www.ncbi.nlm.nih.gov/pubmed/34933920
http://dx.doi.org/10.26508/lsa.202101185
_version_ 1784623444373012480
author Riera-Tur, Irene
Schäfer, Tillman
Hornburg, Daniel
Mishra, Archana
da Silva Padilha, Miguel
Fernández-Mosquera, Lorena
Feigenbutz, Dennis
Auer, Patrick
Mann, Matthias
Baumeister, Wolfgang
Klein, Rüdiger
Meissner, Felix
Raimundo, Nuno
Fernández-Busnadiego, Rubén
Dudanova, Irina
author_facet Riera-Tur, Irene
Schäfer, Tillman
Hornburg, Daniel
Mishra, Archana
da Silva Padilha, Miguel
Fernández-Mosquera, Lorena
Feigenbutz, Dennis
Auer, Patrick
Mann, Matthias
Baumeister, Wolfgang
Klein, Rüdiger
Meissner, Felix
Raimundo, Nuno
Fernández-Busnadiego, Rubén
Dudanova, Irina
author_sort Riera-Tur, Irene
collection PubMed
description The autophagy-lysosomal pathway is impaired in many neurodegenerative diseases characterized by protein aggregation, but the link between aggregation and lysosomal dysfunction remains poorly understood. Here, we combine cryo-electron tomography, proteomics, and cell biology studies to investigate the effects of protein aggregates in primary neurons. We use artificial amyloid-like β-sheet proteins (β proteins) to focus on the gain-of-function aspect of aggregation. These proteins form fibrillar aggregates and cause neurotoxicity. We show that late stages of autophagy are impaired by the aggregates, resulting in lysosomal alterations reminiscent of lysosomal storage disorders. Mechanistically, β proteins interact with and sequester AP-3 μ1, a subunit of the AP-3 adaptor complex involved in protein trafficking to lysosomal organelles. This leads to destabilization of the AP-3 complex, missorting of AP-3 cargo, and lysosomal defects. Restoring AP-3μ1 expression ameliorates neurotoxicity caused by β proteins. Altogether, our results highlight the link between protein aggregation, lysosomal impairments, and neurotoxicity.
format Online
Article
Text
id pubmed-8711852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Life Science Alliance LLC
record_format MEDLINE/PubMed
spelling pubmed-87118522022-01-21 Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity Riera-Tur, Irene Schäfer, Tillman Hornburg, Daniel Mishra, Archana da Silva Padilha, Miguel Fernández-Mosquera, Lorena Feigenbutz, Dennis Auer, Patrick Mann, Matthias Baumeister, Wolfgang Klein, Rüdiger Meissner, Felix Raimundo, Nuno Fernández-Busnadiego, Rubén Dudanova, Irina Life Sci Alliance Research Articles The autophagy-lysosomal pathway is impaired in many neurodegenerative diseases characterized by protein aggregation, but the link between aggregation and lysosomal dysfunction remains poorly understood. Here, we combine cryo-electron tomography, proteomics, and cell biology studies to investigate the effects of protein aggregates in primary neurons. We use artificial amyloid-like β-sheet proteins (β proteins) to focus on the gain-of-function aspect of aggregation. These proteins form fibrillar aggregates and cause neurotoxicity. We show that late stages of autophagy are impaired by the aggregates, resulting in lysosomal alterations reminiscent of lysosomal storage disorders. Mechanistically, β proteins interact with and sequester AP-3 μ1, a subunit of the AP-3 adaptor complex involved in protein trafficking to lysosomal organelles. This leads to destabilization of the AP-3 complex, missorting of AP-3 cargo, and lysosomal defects. Restoring AP-3μ1 expression ameliorates neurotoxicity caused by β proteins. Altogether, our results highlight the link between protein aggregation, lysosomal impairments, and neurotoxicity. Life Science Alliance LLC 2021-12-21 /pmc/articles/PMC8711852/ /pubmed/34933920 http://dx.doi.org/10.26508/lsa.202101185 Text en © 2021 Riera-Tur et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Articles
Riera-Tur, Irene
Schäfer, Tillman
Hornburg, Daniel
Mishra, Archana
da Silva Padilha, Miguel
Fernández-Mosquera, Lorena
Feigenbutz, Dennis
Auer, Patrick
Mann, Matthias
Baumeister, Wolfgang
Klein, Rüdiger
Meissner, Felix
Raimundo, Nuno
Fernández-Busnadiego, Rubén
Dudanova, Irina
Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
title Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
title_full Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
title_fullStr Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
title_full_unstemmed Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
title_short Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
title_sort amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711852/
https://www.ncbi.nlm.nih.gov/pubmed/34933920
http://dx.doi.org/10.26508/lsa.202101185
work_keys_str_mv AT rieraturirene amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT schafertillman amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT hornburgdaniel amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT mishraarchana amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT dasilvapadilhamiguel amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT fernandezmosqueralorena amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT feigenbutzdennis amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT auerpatrick amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT mannmatthias amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT baumeisterwolfgang amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT kleinrudiger amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT meissnerfelix amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT raimundonuno amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT fernandezbusnadiegoruben amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity
AT dudanovairina amyloidlikeaggregatingproteinscauselysosomaldefectsinneuronsviagainoffunctiontoxicity